| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/31/2001 | US6267782 Medical article with adhered antimicrobial metal |
| 07/31/2001 | CA2214713C Topical antimicrobial agents |
| 07/31/2001 | CA2118119C Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 07/31/2001 | CA2068763C Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| 07/31/2001 | CA2023944C Use of phospholipid derivatives as antiviral pharmaceutical and new phospholipids |
| 07/26/2001 | WO2001053541A1 Antisense modulation of caspase 8 expression |
| 07/26/2001 | WO2001053506A2 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | WO2001053505A2 Herpes virus strains for gene therapy |
| 07/26/2001 | WO2001053487A2 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | WO2001053444A1 Antimicrobial compositions |
| 07/26/2001 | WO2001053343A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | WO2001053342A1 Chimeric prostate-homing peptides with pro-apoptotic activity |
| 07/26/2001 | WO2001053330A2 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them |
| 07/26/2001 | WO2001053322A2 Aerothricin analogs, their preparation and use |
| 07/26/2001 | WO2001053305A1 Processes for the preparation of carbapenem derivatives |
| 07/26/2001 | WO2001053297A1 Alpha v integrin receptor antagonists |
| 07/26/2001 | WO2001053289A1 Anticancer compound and enantiomer separation method useful for synthesizing said compound |
| 07/26/2001 | WO2001053273A1 3-aminoquinazolin-2,4-dione antibacterial agents |
| 07/26/2001 | WO2001053263A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | WO2001053261A1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 07/26/2001 | WO2001052895A1 Pharmaceutical compositions comprising terbinafine |
| 07/26/2001 | WO2001052894A2 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | WO2001052893A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | WO2001052888A2 Improved dna vaccines for production-type animals |
| 07/26/2001 | WO2001052887A2 Vaccination against canine herpesvirus infection and vaccines |
| 07/26/2001 | WO2001052885A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 07/26/2001 | WO2001052884A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/26/2001 | WO2001052874A2 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
| 07/26/2001 | WO2001052852A1 Water soluble prodrugs of azole compounds |
| 07/26/2001 | WO2001052846A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | WO2001052845A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | WO2001052824A2 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 07/26/2001 | WO2001052821A1 Improved pharmaceutical formulations |
| 07/26/2001 | WO2001052791A2 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 07/26/2001 | WO2001052667A2 Pet food composition for treating helicobacter species in pets |
| 07/26/2001 | WO2001019811A3 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |
| 07/26/2001 | WO2001017548A3 Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections |
| 07/26/2001 | WO2001017535A3 Enriched fraction from a porcine liver extract for treating human diseases |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001004148A9 Donor strand complemented pilin and adhesin broad-based vaccines |
| 07/26/2001 | WO2000075336A3 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines |
| 07/26/2001 | WO2000075180A3 Peptides for vaccinating against human cmv |
| 07/26/2001 | WO2000066156A8 Death domain containing receptor 5 |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | WO2000015178A3 Computer implemented pharmacokinetics method and program |
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses |
| 07/26/2001 | US20010009959 Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies |
| 07/26/2001 | US20010009957 Invaplex from gram negative bacteria, method of purification and methods of use |
| 07/26/2001 | US20010009924 Methods of providing symptomatic and prophylactic neuroprotection |
| 07/26/2001 | US20010009919 Tris benzimidazoles; fungicides, anticarcinogenic agents, enzyme inhibitor |
| 07/26/2001 | US20010009914 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 07/26/2001 | US20010009906 Treatment of HIV-infected human in alternation or combination with second anti-HIV drug that induces mutation pattern at other than 70th codon of reverse transcriptase region location; drug resistance, pharmokinetics |
| 07/26/2001 | US20010009669 Inactive flavivirus such as tick-born encephalitis (TBE) virus, an immunogenic component bonded to the flavivirus or adsorbed therewith |
| 07/26/2001 | US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr) |
| 07/26/2001 | US20010009666 Acellular pertussis vaccines and methods of preparation thereof |
| 07/26/2001 | US20010009661 Preparing an iodine demand disinfectant by contacting at high temperature and pressure a porous strong base anion exchange resin in salt form with iodine or polyiodide ion absorbable by the resin to form the polyiodide-resin |
| 07/26/2001 | DE10002509A1 New substituted glutarimide derivatives are IL-12 antagonists, are useful as immunomodulators and for the treatment of angiopathy, hematological or oncological disorders |
| 07/26/2001 | DE10001729A1 Treatment or prevention of hepatitis C infection by administration of certain bicyclic compounds, e.g. 2-methyl-1,4-naphthoquinone |
| 07/26/2001 | DE10001172A1 Templatieren von Feststoffpartikeln mit Polymermultischichten Templating of solid particles with polymer multilayers |
| 07/26/2001 | CA2743326A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 07/26/2001 | CA2398343A1 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | CA2398086A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis |
| 07/26/2001 | CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production |
| 07/26/2001 | CA2397896A1 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | CA2397861A1 Vaccination against canine herpesvirosis and vaccines therefor |
| 07/26/2001 | CA2397729A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/26/2001 | CA2397686A1 Gyrase inhibitors and uses thereof |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397508A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 07/26/2001 | CA2396381A1 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2394612A1 Antimicrobial compositions |
| 07/26/2001 | CA2393694A1 Use of particular compounds for prophylaxis and treatment of hepatitis c |
| 07/25/2001 | EP1118858A2 Assay method |
| 07/25/2001 | EP1118678A1 Method for diagnosing polymorphisms in the human PDH E1 beta gene |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118659A1 Expression systems for functional nucleic acid expression |
| 07/25/2001 | EP1118331A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/25/2001 | EP1117824A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
| 07/25/2001 | EP1117807A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117772A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 07/25/2001 | EP1117769A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 07/25/2001 | EP1117767A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 07/25/2001 | EP1117695A1 Biocompatible polymers, preparation method and compositions containing same |
| 07/25/2001 | EP1117669A1 Antiviral purine derivatives |
| 07/25/2001 | EP1117652A1 Tan-1057 derivatives |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117640A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 07/25/2001 | EP1117441A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/25/2001 | EP1117436A1 Neisseria spp polypeptide, nucleic acid sequence and uses thereof |
| 07/25/2001 | EP1117434A2 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 07/25/2001 | EP1117433A1 Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens |
| 07/25/2001 | EP1117432A1 Carbohydrate vaccines for viral diseases |
| 07/25/2001 | EP1117415A1 Use of extracts from aristolochia in the treatment of aids |